Skip to main content

Nephrology Articles tagged as Randomized Trial

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Edmund J. Lewis, M.D., Lawrence G. Hunsicker, M.D., William R. Clarke, Ph.D., Tomas Berl, M.D., Marc A. Pohl, M.D., Julia B. Lewis, M.D., Eberhard Ritz, M.D., Robert C. Atkins, M.D., Richard Rohde, B.S., and Itamar Raz, M.D., for the Collaborative Study G
N Engl J Med. 2001 Sep 20;345(12):851-60

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, John
JAMA. 2001 Jun 6;285(21):2719-28

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Frank M. Sacks, M.D., Laura P. Svetkey, M.D., William M. Vollmer, Ph.D., Lawrence J. Appel, M.D., George A. Bray, M.D., David Harsha, Ph.D., Eva Obarzanek, Ph.D., Paul R. Conlin, M.D., Edgar R. Miller, M.D., Ph.D., Denise G. Simons-Morton, M.D., Ph.D., Nj
N Engl J Med. 2001 Jan 4;344(1):3-10

Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
N Engl J Med. 2000 Jan 20;342(3):145-53

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

Mark F. Gourley, MD; Howard A. Austin III, MD; Dorothy Scott, MD; Cheryl H. Yarboro, RN; Ellen M. Vaughan, RN; Joanne Muir, RN; Dimitrios T. Boumpas, MD; John H. Klippel, MD; James E. Balow, MD; and Alfred D. Steinberg, MD
Ann Intern Med. 1996 Oct 1;125(7):549-57
<<  1 2 3 4 [5
ukidneyisup